Wiselight - This agreement with a US investment banker certainly isn't bad news, but...what's the need? Raytec has good relationships with corporations that have pretty deep pockets, and appears to be marketing dmCLO2 products to the food marketing side only, leaving other development and marketing to others, and drawing in money thru licensing fees. Again, if this is so good, where are the people who are buying in to this imminent success story? I'm not trashing the stock (I'm long) but some aspects of this story have gaps that I don't fully understand. Could it be that Raytec's take from the sale of this product will be unacceptably small? Sure would like to see some news...the only thing keeping this thread, and the Stockhouse thread, going is a series of posts from people who have passed on stuff they've heard by rumour, or over the phone with the company. It's weird - like having shares in the sphinx: buy in and wait a thousand years for some news. Oh, well, you pays yer money and you takes yer choice - see someone bought 15K shares this morning. Regards, JK |